Skip to main content
. 2018 Feb 6;8:2487. doi: 10.1038/s41598-018-20531-w

Figure 4.

Figure 4

(A) Effect of QC treatment on NTC and p62 knockdown (shRNA 280) OV2008 cells for 24 hours. Cells were harvested and subjected to Western blot analysis using anti-cleaved PARP, anti-cleaved PARP, anti-p62/SQSTM1, anti-p21 and anti-beta actin antibodies. (B) Effect of QC treatment on NTC and p62 knockdown (shRNA clone1and shRNA clone2) C13 cells for 24 hours. Cells were harvested and subjected to Western blot analysis using anti-cleaved PARP, anti-cleaved PARP, anti-p62/SQSTM1, anti-p21 and anti-beta actin antibodies.